US Stock MarketDetailed Quotes

CLDI Calidi Biotherapeutics

Watchlist

2.140
-0.010-0.47%

Close Nov 22 16:00 ET

2.101
-0.039-1.83%

Post 20:01 ET

37.48MMarket Cap-713P/E (TTM)

Calidi Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-89.98%45K

Operating revenue

--0

-89.98%45K

--0

Cost of revenue

-85.11%14K

Gross profit

-91.27%31K

Operating expense

-19.94%5.23M

-1.01%5.59M

42.96%6.75M

12.73%26.11M

96.42%9.21M

-6.56%6.53M

5.65M

4.72M

113.70%23.16M

41.20%4.69M

Selling and administrative expenses

-22.59%3.07M

7.29%3.61M

43.59%4.01M

0.52%15.98M

141.73%5.86M

-21.25%3.97M

--3.36M

--2.79M

158.02%15.9M

24.68%2.43M

-General and administrative expense

-22.59%3.07M

7.29%3.61M

43.59%4.01M

0.52%15.98M

141.73%5.86M

-21.25%3.97M

--3.36M

--2.79M

158.02%15.9M

24.68%2.43M

Research and development costs

-33.77%2.15M

-31.79%2.17M

4.61%2.74M

79.25%13.01M

74.90%3.96M

67.15%3.25M

--3.18M

--2.62M

55.26%7.26M

64.58%2.26M

Other operating expenses

----

79.64%-181K

----

---2.89M

---612K

---693K

---889K

---691K

----

Operating profit

19.94%-5.23M

1.01%-5.59M

-42.96%-6.75M

-12.88%-26.11M

-96.42%-9.21M

6.56%-6.53M

-5.65M

-4.72M

-120.64%-23.13M

-58.11%-4.69M

Net non-operating interest income expense

28.40%-232K

90.86%-273K

-16.59%-253K

-2,272.78%-3.75M

-126.53%-222K

-1,017.24%-324K

-2.99M

-217K

74.27%-158K

-58.06%-98K

Non-operating interest expense

-28.40%232K

-10.78%273K

16.59%253K

576.58%1.07M

126.53%222K

1,017.24%324K

--306K

--217K

-74.27%158K

58.06%98K

Total other finance cost

----

--2.68M

--0

----

--2.68M

----

Other net income (expense)

-91.98%388K

102.72%105K

85.77%-216K

130.80%656K

140.30%1.2M

191.33%4.84M

-3.86M

-1.52M

-1,324.14%-2.13M

-547.71%-2.97M

Gain on sale of security

-92.85%380K

102.47%95K

86.85%-199K

155.44%1.18M

141.22%1.22M

220.94%5.32M

---3.85M

---1.51M

-1,032.02%-2.13M

-257.92%-2.96M

Special income (charges)

--0

----

---471K

--0

---471K

----

--0

-Less:Other special charges

----

--471K

--0

--471K

----

Other non- operating income (expenses)

200.00%8K

162.50%10K

-240.00%-17K

-920.00%-51K

-69.23%-22K

-300.00%-8K

---16K

---5K

-155.56%-5K

-316.67%-13K

Income before tax

-151.86%-5.07M

53.92%-5.76M

-11.81%-7.22M

-14.89%-29.2M

-6.10%-8.23M

62.40%-2.01M

-12.5M

-6.46M

-132.70%-25.42M

-122.58%-7.76M

Income tax

-109.09%-1K

100.00%8K

0.00%4K

45.45%16K

0.00%-3K

1,000.00%11K

0.00%11K

-200.00%-3K

Net income

-150.44%-5.07M

53.87%-5.77M

-11.81%-7.23M

-14.90%-29.22M

-6.10%-8.23M

62.20%-2.02M

-12.5M

-6.46M

-132.57%-25.43M

-122.30%-7.76M

Net income continuous Operations

-150.44%-5.07M

53.87%-5.77M

-11.81%-7.23M

-14.90%-29.22M

-6.10%-8.23M

62.20%-2.02M

---12.5M

---6.46M

-132.57%-25.43M

-122.30%-7.76M

Minority interest income

-15K

Net income attributable to the parent company

-149.70%-5.05M

53.87%-5.77M

-11.81%-7.23M

-14.90%-29.22M

-6.10%-8.23M

62.20%-2.02M

-12.5M

-6.46M

-132.57%-25.43M

-122.30%-7.76M

Preferred stock dividends

Other preferred stock dividends

1.67M

Net income attributable to common stockholders

-149.70%-5.05M

40.50%-7.44M

-11.81%-7.23M

-14.90%-29.22M

-6.10%-8.23M

62.20%-2.02M

-12.5M

-6.46M

-132.57%-25.43M

-122.30%-7.76M

Basic earnings per share

53.90%-0.65

-302.12%-14

-11.13%-2

-144.30%-17.3

-7.25%-2.3166

5.46%-1.41

-3.4815

-1.7997

-132.57%-7.0814

-122.30%-2.1601

Diluted earnings per share

53.90%-0.65

-302.12%-14

-11.13%-2

-144.30%-17.3

-7.25%-2.3166

5.46%-1.41

-3.4815

-1.7997

-132.57%-7.0814

-122.30%-2.1601

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	-89.98%45K	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	-89.98%45K	--0
Cost of revenue				0					-85.11%14K	0
Gross profit				0					-91.27%31K	0
Operating expense	-19.94%5.23M	-1.01%5.59M	42.96%6.75M	12.73%26.11M	96.42%9.21M	-6.56%6.53M	5.65M	4.72M	113.70%23.16M	41.20%4.69M
Selling and administrative expenses	-22.59%3.07M	7.29%3.61M	43.59%4.01M	0.52%15.98M	141.73%5.86M	-21.25%3.97M	--3.36M	--2.79M	158.02%15.9M	24.68%2.43M
-General and administrative expense	-22.59%3.07M	7.29%3.61M	43.59%4.01M	0.52%15.98M	141.73%5.86M	-21.25%3.97M	--3.36M	--2.79M	158.02%15.9M	24.68%2.43M
Research and development costs	-33.77%2.15M	-31.79%2.17M	4.61%2.74M	79.25%13.01M	74.90%3.96M	67.15%3.25M	--3.18M	--2.62M	55.26%7.26M	64.58%2.26M
Other operating expenses	----	79.64%-181K	----	---2.89M	---612K	---693K	---889K	---691K	----	----
Operating profit	19.94%-5.23M	1.01%-5.59M	-42.96%-6.75M	-12.88%-26.11M	-96.42%-9.21M	6.56%-6.53M	-5.65M	-4.72M	-120.64%-23.13M	-58.11%-4.69M
Net non-operating interest income expense	28.40%-232K	90.86%-273K	-16.59%-253K	-2,272.78%-3.75M	-126.53%-222K	-1,017.24%-324K	-2.99M	-217K	74.27%-158K	-58.06%-98K
Non-operating interest expense	-28.40%232K	-10.78%273K	16.59%253K	576.58%1.07M	126.53%222K	1,017.24%324K	--306K	--217K	-74.27%158K	58.06%98K
Total other finance cost	----	----	----	--2.68M	--0	----	--2.68M	----	----	----
Other net income (expense)	-91.98%388K	102.72%105K	85.77%-216K	130.80%656K	140.30%1.2M	191.33%4.84M	-3.86M	-1.52M	-1,324.14%-2.13M	-547.71%-2.97M
Gain on sale of security	-92.85%380K	102.47%95K	86.85%-199K	155.44%1.18M	141.22%1.22M	220.94%5.32M	---3.85M	---1.51M	-1,032.02%-2.13M	-257.92%-2.96M
Special income (charges)	--0	----	----	---471K	--0	---471K	----	----	--0	--0
-Less:Other special charges	----	----	----	--471K	--0	--471K	----	----	----	----
Other non- operating income (expenses)	200.00%8K	162.50%10K	-240.00%-17K	-920.00%-51K	-69.23%-22K	-300.00%-8K	---16K	---5K	-155.56%-5K	-316.67%-13K
Income before tax	-151.86%-5.07M	53.92%-5.76M	-11.81%-7.22M	-14.89%-29.2M	-6.10%-8.23M	62.40%-2.01M	-12.5M	-6.46M	-132.70%-25.42M	-122.58%-7.76M
Income tax	-109.09%-1K	100.00%8K	0.00%4K	45.45%16K	0.00%-3K	1,000.00%11K	4K	4K	0.00%11K	-200.00%-3K
Net income	-150.44%-5.07M	53.87%-5.77M	-11.81%-7.23M	-14.90%-29.22M	-6.10%-8.23M	62.20%-2.02M	-12.5M	-6.46M	-132.57%-25.43M	-122.30%-7.76M
Net income continuous Operations	-150.44%-5.07M	53.87%-5.77M	-11.81%-7.23M	-14.90%-29.22M	-6.10%-8.23M	62.20%-2.02M	---12.5M	---6.46M	-132.57%-25.43M	-122.30%-7.76M
Minority interest income	-15K					0
Net income attributable to the parent company	-149.70%-5.05M	53.87%-5.77M	-11.81%-7.23M	-14.90%-29.22M	-6.10%-8.23M	62.20%-2.02M	-12.5M	-6.46M	-132.57%-25.43M	-122.30%-7.76M
Preferred stock dividends
Other preferred stock dividends	0	1.67M				0	0
Net income attributable to common stockholders	-149.70%-5.05M	40.50%-7.44M	-11.81%-7.23M	-14.90%-29.22M	-6.10%-8.23M	62.20%-2.02M	-12.5M	-6.46M	-132.57%-25.43M	-122.30%-7.76M
Basic earnings per share	53.90%-0.65	-302.12%-14	-11.13%-2	-144.30%-17.3	-7.25%-2.3166	5.46%-1.41	-3.4815	-1.7997	-132.57%-7.0814	-122.30%-2.1601
Diluted earnings per share	53.90%-0.65	-302.12%-14	-11.13%-2	-144.30%-17.3	-7.25%-2.3166	5.46%-1.41	-3.4815	-1.7997	-132.57%-7.0814	-122.30%-2.1601
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data